Pages
Categories
- Events (9)
- Featured (13)
- News (14)
- Uncategorized (2)
Posts per category
Events
- BIO International Convention 2013: Rachel King Interviewed By Women In Bio - Comments (0)
- GlycoMimetics CEO Rachel King Named BIO Chairwoman for 2013-2014 Term - Comments (0)
- Tech Council of Maryland Honors GlycoMimetics’ Chairman of the Board James Barrett with Lifetime Achievement Award - Comments (0)
- GlycoMimetics CMO Helen Thackray Featured as Industry Expert in BIO’s Webinar Series on FDASIA & PDUFA Reauthorization - Comments (0)
- GlycoMimetics CEO Rachel King Among Panelists Featured in Keynote Session at 2012 BIO International Convention - Comments (0)
- GlycoMimetics Featured in BIO Program — From Despair to Hope: A New World of Therapies - Comments (0)
- GlycoMimetics CEO Rachel King Joins Pfizer, MedImmune, HGSI and Aratana for MdBio Leadership Panel on Partnering with Big Pharma - Comments (0)
- GlycoMimetics CSO John Magnani Among Featured Panelists at the NIAID AIDS Vaccine Symposium - Comments (0)
- GlycoMimetics CSO John Magnani Presented to National Academy of Sciences Committee Assessing Glycobiology - Comments (0)
Featured
- Tech Council of Maryland Names Glycomimetics CEO Rachel King as 2013 Executive of the Year - Comments (0)
- The Download: Rachel King named chairwoman of Biotechnology Industry Organization board - Comments (0)
- GlycoMimetics Announces Top Line Results from Phase 2 Trial with GMI-1070 in Sickle Cell Disease - Comments (0)
- GlycoMimetics Completes Enrollment in Phase 2 Sickle Cell Disease Study with Lead Drug Candidate GMI-1070 - Comments (0)
- GlycoMimetics Announces Progress from its Novel Compounds as Presented at 2012 American Society of Hematology Annual Meeting - Comments (0)
- Glycomimetics Announces Publication in Nature Medicine of Preclinical Data for its GMI-1070 Drug Candidate - Comments (0)
- GlycoMimetics, Inc. Announces Presentation at National Sickle Cell Conference - Comments (0)
- William E. Proudford Sickle Cell Fund Honors GlycoMimetics, Inc. With “Unsung Hero” Award - Comments (0)
- GlycoMimetics CMO Helen Thackray Featured as Industry Expert in BIO’s Webinar Series on FDASIA & PDUFA Reauthorization - Comments (0)
- Pfizer Chief Medical Officer Freda Lewis-Hall, M.D., Highlights Pfizer/GlycoMimetics Partnership in Blog Post on Essence Music Festival Panel: “The 2012 Black Women’s Agenda: The High Cost of Living in America” - Comments (0)
News
- GlycoMimetics CEO Rachel King named Maryland Life Sciences Advisory Board Chair - Comments (0)
- The Download: Rachel King named chairwoman of Biotechnology Industry Organization board - Comments (0)
- BIO elects GlycoMimetics’ Rachel King as new chair - Comments (0)
- GlycoMimetics completes enrolment in GMI-1070 Phase II sickle cell disease study - Comments (0)
- Pfizer Chief Medical Officer Freda Lewis-Hall, M.D., Highlights Pfizer/GlycoMimetics Partnership in Blog Post on Essence Music Festival Panel: “The 2012 Black Women’s Agenda: The High Cost of Living in America” - Comments (0)
- Thackray helps spearhead GlycoMimetics’ therapeutic efforts - Comments (0)
- Female Frontrunners: How to successfully surmount the challenges women face in becoming biotech industry leaders - Comments (0)
- Pfizer Q4 Results with GlycoMimetics Mention - Comments (0)
- Pfizer inks $340M rare disease pact with GlycoMimetics - Comments (0)
- Hope for Sickle Cell Patients…GlycoMimetics Paving the Way - Comments (0)